Merck (MRK) Tops Q2 EPS by 33c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $127.00 +0.09%
EPS Growth %: +37.9%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: +37.9%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of $1.37, $0.33 better than the analyst estimate of $1.04. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $10.39 billion.
GUIDANCE:
Merck sees FY2020 EPS of $5.63-$5.78, versus the consensus of $5.31. Merck sees FY2020 revenue of $47.2-48.7 billion, versus the consensus of $47.3 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
- Alerus Financial Corporation (ALRS) Reports In-Line Q1 EPS
- ChampionX (CHX) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
